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Restless legs syndrome is common in patients with multiple sclerosis but has not been reported as occurring due to an acute,
inﬂammatory, demyelinating attack. Restless legs syndrome is known to be related to low brain iron levels. Multiple sclerosis has
been associated with the abnormal accumulation of iron in the chronic, progressive phase of axonal degeneration. Iron deﬁciency
may play a role in demyelination. This suggests that restless legs syndrome may be caused by the inﬂammatory, demyelinating
component of multiple sclerosis rather than axonal degeneration. The author presents a case of self-limited restless legs syndrome
occurring as an acute attack of multiple sclerosis, supporting the notion that inﬂammatory demyelination is the underlying
pathophysiology of restless legs syndrome in multiple sclerosis.
1.CaseReport
The patient was a 25-year-old, right-handed woman who
presented two months after the sudden onset of lower
extremity paresthesias and sensory loss that extended into
the abdomen and lower chest and one episode of urinary
urgency and subsequent incontinence. Her examination was
notable forbrisk lower extremity deep tendon reﬂexes butno
other abnormalities. MRI of the cervical and thoracic spine
revealed both cervical and midthoracic plaques consistent
with demyelination. A subsequent brain MRI revealed ﬁve
scattered, nonenhancing, white-matter lesions; including a
large (approximately 5mm in diameter) lesion involving the
corpus callosum and two lesions perpendicular to the left
lateral ventricle. Her B12 level, HTLV-1 antibodies, vitamin
E level, RPR, ANA, and Lyme titre were all within normal
limits She was started on glatiramer acetate following her
clinically isolated syndrome of partial transverse myelitis
and MRI ﬁndings conﬁrming dissemination in space. Two
and a half years after her initial presentation, she developed
right hemiparesis that resolved over a few days following
treatment with intravenous steroids. She had a subsequent
similar episode of left hemiparesis and hemisensory deﬁcit
two months after that, conﬁrming a diagnosis of clinically
deﬁnite multiple sclerosis.
One year after her initial presentation, she developed a
sudden onset of discomfort in her legs associated with an
urgetomovethatwasworseatnight andimpaired sleep. The
symptom resolved while walking and had been present for
only 3-4 days at the time of presentation. Her last menstrual
period was two weeks prior to this presentation, and she
was faithfully using an oral contraceptive. Her iron level
was 108mcg/dl, iron saturation was 28.6%, and ferritin was
94ng/ml. A brain MRI did not reveal any new lesions. Her
symptoms resolved a few days after a course of intravenous
methylprednisolone (1g daily for three days), and she had
no recurrence over the next three years.
2. Discussion
Restless legs syndrome is a movement disorder characterized
by distressing urge to move the legs (akathisia) associated
with discomfort and that is brought on by rest, relieved by
movement or walking, and become worse at night or in
the evening [1]. The patient described above fulﬁlled all of2 Multiple Sclerosis International
these diagnostic criteria. Her rather abrupt onset suggested
the possibility of restless legs syndrome secondary to an
underlyingcause,suchaspregnancyorirondeﬁciency.How-
ever, her diagnostic evaluation excluded these possibilities,
and her clinical course and probable response to steroids
suggested that her restless legs syndrome was due to an acute
exacerbation of her multiple sclerosis.
Several studies have reported an increased incidence of
restless legs syndrome in patients with multiple sclerosis,
have suggested both a role for restless legs syndrome in MS-
related fatigue, and have suggested that multiple sclerosis is
a cause of secondary restless legs syndrome [2–5]. However,
none of these studies describe self-limited restless legs
syndrome occurring as an acute exacerbation of multiple
sclerosis as in this case. Manconi et al. demonstrated a
correlation between RLS and cervical cord lesion burden
[6]. This patient had a known cervical cord plaque, and this
correlationmightalsoexplainwhynonewintracraniallesion
was detected during her acute presentation with RLS.
Restless legs syndrome is commonly idiopathic, but it
has been associated with a number of conditions other
than multiple sclerosis, including pregnancy, renal failure,
peripheral neuropathy, and iron deﬁciency [1, 7]. Iron
deﬁciency has been recognized in several studies as a cause
for secondary restless legs syndrome, particularly at serum
ferritin concentrations of less than 50ng/ml [7–10]. The
pathophysiology of even idiopathic restless legs syndrome is
probably related to low brain iron levels [1]. MRI, CSF, and
neuropathologicalstudieshaveallimplicatedcentralnervous
system iron deﬁciency in the pathophysiology of restless legs
syndrome, even in the absence of systemic iron deﬁciency
[11–16]. Recently, there has been interest in the role of
iron in MS and iron deposition because cerebral venous
insuﬃciency has been suggested as a proposed mechanism
for the disease [17]. Haacke et al. reported MRI evidence
of iron accumulation in the basal ganglia and thalamus of
MS patients [18]. However, CSF studies have demonstrated
normal CSF ferritin levels in MS [19]. Furthermore, iron
appearstobeanimportantcofactorinCNSmyelination,and
van Toorn et al. have reported two cases of iron deﬁciency
associated with tumefactive demyelination in children [20–
22].
The pathophysiology of MS consists of both an inﬂam-
matory demyelinating component and an axonal degen-
eration component [23]. LeVine et al. reported normal
CSF ferritin, transferrin, and iron concentrations in MS
patients with stable or relapsing and remitting MS, but
elevatedlevelsintheCSFofpatientswithchronicprogressive
MS [24]. Therefore, it is likely that the pathophysiology
of RLS in MS patients is related to the inﬂammatory,
demyelinating component of the disease which may be
associated with low or normal CNS iron levels, rather than
due to axonal degeneration, which is associated with CNS
iron accumulation. The observation that RLS is associated
with spinal cord plaques would also suggest a relationship to
the inﬂammatory and demyelinating component of disease
[6]. This patient, presenting with transient RLS due to an
acute, inﬂammatory exacerbation of her multiple sclerosis,
further supports the notion that the pathophysiology of RLS
in multiple sclerosis is related to autoimmune inﬂammatory
demyelination.
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